These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4843531)

  • 21. Comparative uptake of adriamycin and daunorubicin in sensitive and resistant friend leukemia cells measured by flow cytometry.
    Tapiero H; Fourcade A; Vaigot P; Farhi JJ
    Cytometry; 1982 Mar; 2(5):298-302. PubMed ID: 6951693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytofluorescence localization of adriamycin in resistant colon cancer cells.
    Chauffert B; Martin F; Caignard A; Jeannin JF; Leclerc A
    Cancer Chemother Pharmacol; 1984; 13(1):14-8. PubMed ID: 6733840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodistribution of intravenously injected [14C] doxorubicin and [14C] daunorubicin in mice: concise communication.
    Harrison K; Wagner NH
    J Nucl Med; 1978 Jan; 19(1):84-6. PubMed ID: 621570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Daunomycin and adriamycin metabolism via reductive glycosidic cleavage.
    Asbell MA; Schwartzbach E; Bullock FJ; Yesair DW
    J Pharmacol Exp Ther; 1972 Jul; 182(1):63-9. PubMed ID: 5041655
    [No Abstract]   [Full Text] [Related]  

  • 25. Proceedings: Daunomycin and adriamycin antitumor cell antibody conjugates.
    Hurwitz E; Levy R; Maron R
    Isr J Med Sci; 1975 Dec; 11(12):1396. PubMed ID: 1218993
    [No Abstract]   [Full Text] [Related]  

  • 26. Individual nuclear uptake patterns for adriamycin and daunomycin in human leukemia and lymphoma cells.
    Seeber S; Loth H
    Blut; 1981 Jun; 42(6):355-65. PubMed ID: 6941824
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative pharmacokinetics of daunomycin and adriamycin in several animal species.
    Yesair DW; Schwartzbach E; Shuck D; Denine EP; Asbell MA
    Cancer Res; 1972 Jun; 32(6):1177-83. PubMed ID: 5030818
    [No Abstract]   [Full Text] [Related]  

  • 28. Current status of studies with adriamycin (NSC-123127).
    Bachur NR
    Cancer Chemother Rep 3; 1973 May; 4(3):47-50. PubMed ID: 4795942
    [No Abstract]   [Full Text] [Related]  

  • 29. Body residue and metabolism of adriamycin and daunorubicin in control and phenobarbital-pretreated mice.
    Bolanowska W; Gessner T
    Xenobiotica; 1982 Feb; 12(2):125-36. PubMed ID: 7090422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of chromatin structure induced by the binding of adriamycin, daunorubicin and ethidium bromide.
    Grimmond HE; Beerman T
    Biochem Pharmacol; 1982 Nov; 31(21):3379-86. PubMed ID: 7150361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An assay to measure adriamycin binding in osteosarcoma cells.
    Gebhardt MC; Kusuzaki K; Mankin HJ; Springfield DS
    J Orthop Res; 1994 Sep; 12(5):621-7. PubMed ID: 7931778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double fluorescence method for determining doxorubicin distribution and vascular supply in the mouse kidney.
    Paschoud N; Bignell C; Reinhold HS
    J Histochem Cytochem; 1985 Jan; 33(1):73-6. PubMed ID: 2578145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial biotransformations of daunorubicin to aglycones by rat liver microsomes.
    Schwartz HS; Parker NB
    Cancer Res; 1981 Jun; 41(6):2343-8. PubMed ID: 7237433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction of daunorubicin and doxorubicin with DNA and chromatin.
    Zunino F; Di Marco A; Zaccara A; Gambetta RA
    Biochim Biophys Acta; 1980 Apr; 607(2):206-14. PubMed ID: 7370266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear targeting and nuclear retention of anthracycline-formaldehyde conjugates implicates DNA covalent bonding in the cytotoxic mechanism of anthracyclines.
    Taatjes DJ; Fenick DJ; Koch TH
    Chem Res Toxicol; 1999 Jul; 12(7):588-96. PubMed ID: 10409398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter: Digoxin does not prevent daunorubicin or adriamycin from binding to rat heart muscle.
    Smith BJ; Kundv D
    Br J Cancer; 1976 Feb; 33(2):232-3. PubMed ID: 1259917
    [No Abstract]   [Full Text] [Related]  

  • 37. [Organ and intracellular localization of the biosynthesis of ceruloplasmin].
    Shaposhnikov AM; Zubzhitskiĭ IuN; Mukha GV
    Biokhimiia; 1968; 33(3):629-34. PubMed ID: 4971191
    [No Abstract]   [Full Text] [Related]  

  • 38. Differential fluorescent staining of human chromosomes with daunomycin and adriamycin--the d-bands.
    Lin CC; Van de Sande JH
    Science; 1975 Oct; 190(4209):61-3. PubMed ID: 52193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distribution and metabolism of adriamycin in mice. Comparison with daunomycin.
    Di Fronzo G; Gambetta RA; Lenaz L
    Rev Eur Etud Clin Biol; 1971; 16(6):572-6. PubMed ID: 5125106
    [No Abstract]   [Full Text] [Related]  

  • 40. Another hypothesis concerning the antitumor activity and cardiotoxicity of daunorubicin (NSC-82151) and adriamycin (NSC-123127).
    Wheeler DM
    Cancer Chemother Rep; 1975; 59(2 Pt 1):258-9. PubMed ID: 1149002
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.